These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia. Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046 [TBL] [Abstract][Full Text] [Related]
11. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging. Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R; Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960 [TBL] [Abstract][Full Text] [Related]
12. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum. Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M; Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949 [TBL] [Abstract][Full Text] [Related]
13. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052 [TBL] [Abstract][Full Text] [Related]
14. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease. Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K; Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117 [TBL] [Abstract][Full Text] [Related]
15. Interactive rather than independent effect of Wang YT; Pascoal TA; Therriault J; Kang MS; Benedet AL; Savard M; Tissot C; Lussier FZ; Arias JF; Mathotaarachchi S; Rajah MN; Gauthier S; Rosa-Neto P; Brain Commun; 2021; 3(2):fcab126. PubMed ID: 34189460 [TBL] [Abstract][Full Text] [Related]
17. Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease. Biel D; Luan Y; Brendel M; Hager P; Dewenter A; Moscoso A; Otero Svaldi D; Higgins IA; Pontecorvo M; Römer S; Steward A; Rubinski A; Zheng L; Schöll M; Shcherbinin S; Ewers M; Franzmeier N; Alzheimers Res Ther; 2022 Nov; 14(1):166. PubMed ID: 36345046 [TBL] [Abstract][Full Text] [Related]
18. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease. Pereira JB; Janelidze S; Smith R; Mattsson-Carlgren N; Palmqvist S; Teunissen CE; Zetterberg H; Stomrud E; Ashton NJ; Blennow K; Hansson O Brain; 2021 Dec; 144(11):3505-3516. PubMed ID: 34259835 [TBL] [Abstract][Full Text] [Related]
19. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379 [TBL] [Abstract][Full Text] [Related]
20. Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models. Jablonski AM; Warren L; Usenovic M; Zhou H; Sugam J; Parmentier-Batteur S; Voleti B Sci Rep; 2021 Feb; 11(1):3438. PubMed ID: 33564035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]